The 2026 Talc Verdict Scoreboard: 68,435 Claims, Tried One by One
After its third bankruptcy failed, Johnson & Johnson is fighting 68,435 talc cancer claims in court. Here are the 2026 mesothelioma verdicts, by court.
Latest from the newsroom
Asbestos Trust Funds Hold Over $30 Billion, and Most Pay Cents on the Dollar
Asbestos bankruptcy trusts hold more than $30 billion, but payment percentages mean a claim often pays a small fraction of its scheduled value.
EPA Delays Its Legacy Asbestos Rule to 2027, Seeks Exposure Data
The EPA will propose its Part 2 rule on legacy asbestos and asbestos-containing talc by June 2027 and is taking public exposure data through August 24, 2026.
Where Mesothelioma Forms Shapes How Long People Survive
Pleural mesothelioma is about 81% of US cases and peritoneal about 11%, and the two forms carry very different survival odds, per CDC and SEER data.
Asbestos Use Collapsed Decades Ago. Mesothelioma Deaths Did Not.
US asbestos use fell from 803,000 tons in 1973 to about 110 in 2024, yet mesothelioma deaths did not drop in step, a lag driven by long latency.
Mesothelioma Is Mostly a Men's Disease, and Women's Cases Look Different
Men account for about 3 in 4 US mesothelioma cases, and women's cases skew more toward the peritoneal form, per CDC US Cancer Statistics.
Most People Who Die of Mesothelioma Are Over 75
The 75-84 age group alone was 37% of US mesothelioma deaths from 1999 to 2015, a delayed shadow of mid-century asbestos exposure, per CDC data.
Veterans With Mesothelioma Receive Up to $4,158 a Month Under 2026 VA Rates
Under the 2026 VA rates, a veteran rated 100% for mesothelioma receives $3,938.58 a month alone or $4,158.17 with a spouse, a 2.8% increase.
EPA's Chrysotile Asbestos Ban Stays in Effect as the Fifth Circuit Weighs Industry Challenge
The EPA's 2024 chrysotile asbestos ban remains in effect as the Fifth Circuit weighs a challenge argued June 1, 2026, with a decision pending.
Talc Now Appears in About 1 in 3 US Mesothelioma Lawsuits
Talc allegations appeared in about 35% of 2024 US mesothelioma lawsuits and have nearly doubled as a share of all asbestos filings since 2021, KCIC data show.
Oral Alintegimod (7HP349) Trial Adds Mesothelioma to Its Cohorts
Phase 1b/2a trial NCT06362369 tests oral alintegimod (7HP349), an integrin activator, with ipilimumab then nivolumab. Pleural mesothelioma is one cohort.
Italian Imaging-Meso Study Maps the Mesothelioma Immune Map
Imaging-Meso profiles the immune microenvironment and gene expression of pleural and peritoneal mesothelioma. NCT06581549 is recruiting in Italy.
MDNA11 IL-2 Superkine Trial Includes Pleural Mesothelioma
MDNA11, an engineered IL-2 superkine, is tested alone and with pembrolizumab in the Phase 1/2 ABILITY-1 study (NCT05086692), open to pleural mesothelioma.
Rina-S Trial Adds Mesothelioma to Its Tumor Cohorts
Phase 1/2 trial NCT05579366 tests Rina-S, a folate receptor alpha antibody-drug conjugate from Genmab. Mesothelioma is one of its cohorts.
TNG462 Trial: PRMT5 Inhibitor for MTAP-Deleted Mesothelioma
Phase 1/2 trial (NCT05732831) of TNG462, an oral PRMT5 inhibitor, for MTAP-deleted solid tumors. Mesothelioma is an expansion cohort. Now recruiting.
STEALTH-001 Trial Tests VET3-TGI Oncolytic Virus in Solid Tumors
KaliVir's STEALTH-001 trial (NCT06444815) tests the oncolytic virus VET3-TGI alone and with atezolizumab in advanced solid tumors, mesothelioma among them.
VT3989 TEAD Inhibitor Trial Opens to Mesothelioma Patients
VT3989, a first-in-class YAP/TEAD inhibitor from Vivace Therapeutics, is being tested in a Phase I/II mesothelioma trial (NCT04665206).
Memorial Day 2026: Mesothelioma Still Isn't a VA Presumptive Disease
Mesothelioma wasn't added to the VA presumptive list under the 2022 PACT Act. Most asbestos-exposed veterans still file under direct service connection.
CPSC Recalled 121,340 Orb Funkee Toys and Tested No Other US Brand
CPSC pulled 121,340 Orb Funkee toys for tremolite asbestos on May 21, 2026. It still hasn't tested the other craft-sand brands on US shelves.
New York Jury Awards $25M in American Biltrite Asbestos Tile Case
A New York jury awarded $25 million, including $5 million in punitive damages, to a flooring installer who developed mesothelioma from asbestos floor tiles.
NCI Registry Tracks 1,000 Mesothelioma Patients and Families With BAP1 Mutations (NCT03830229)
An NCI long-term registry follows people with mesothelioma and their relatives carrying germline BAP1 mutations. 1,000-person target. Bethesda. Open enrollment.
Former South African Asbestos Miners Face Higher Mortality, UCT Study Finds
A UCT study of 11,343 former South African asbestos miners found women had 17% higher mortality than expected. Lung function predicted survival.
3D Mesothelioma Spheroids Reveal Why Chemo Often Fails
An Australian team built a 3D mesothelioma spheroid model that mimics tumor resistance to chemo. PI3K/AKT and Notch signaling drive the resistance.
Georgia-Pacific Plans New Bankruptcy, Abandoning Bestwall
Georgia-Pacific has "given up" on its Bestwall bankruptcy and plans a new Chapter 11 to resolve asbestos lawsuits, the Wall Street Journal reports.
ECOG Performance Status and Mesothelioma Prognosis: What the Score Means for Your Options
ECOG, CALGB, EORTC, and the Brims model translate clinical reality into trial eligibility and prognosis. Here is what each score actually measures.
HIPEC and Cytoreductive Surgery for Peritoneal Mesothelioma: Who Qualifies and What to Expect
Cytoreductive surgery with HIPEC has changed peritoneal mesothelioma outcomes. Who qualifies, what the published data show, and what recovery involves.
Mesothelioma Clinical Trial Enrollment: A Practical Guide to Finding, Decoding, and Joining a Trial
How to find a mesothelioma clinical trial, read the listing, decode the eligibility criteria, and understand what enrolling actually involves.
First-Line Mesothelioma Treatment in 2026: Immunotherapy Alone or With Chemotherapy
Two immunotherapy regimens are now first-line for unresectable pleural mesothelioma. Here is what each trial showed and how the decision is framed.
Second-Line Mesothelioma Treatment: When First-Line Stops Working, What Comes Next
When first-line mesothelioma treatment fails, the next decision is rarely between two clear options. Here is what the primary trial evidence supports.
Mesothelioma Survival Rates by Stage and Histology: What the Trial Data Actually Show
Mesothelioma survival numbers by stage and histology from SEER, IASLC, and modern trial data. What the statistics mean, and what they leave out.
Pleurectomy/Decortication vs Extrapleural Pneumonectomy: How Mesothelioma Surgery Decisions Are Made
Two operations dominate the mesothelioma surgical conversation. Here is what the trials, the meta-analyses, and the high-volume centers actually say.
Stage 1 Pleural Mesothelioma: Operable Disease and the Multimodal Treatment Window
For someone newly told their pleural mesothelioma is stage 1: what the AJCC criteria mean and how multimodal therapy is sequenced around surgery.
Stage 2 Pleural Mesothelioma: Borderline-Operable Disease and the Induction-Therapy Decision
Stage 2 pleural mesothelioma sits at the borderline of operable disease. Here is what the AJCC criteria mean and how the induction-therapy decision is framed.
Stage 3 Pleural Mesothelioma: Inoperable Disease, Immunotherapy, and the Active Trial Landscape
Stage III pleural mesothelioma in 2026: what AJCC IIIA and IIIB mean, why most cases are inoperable, and the immunotherapy and trial options.
Mesothelioma Chest Pain: How It Differs from Cardiac, Pleural, and Muscular Causes
Mesothelioma chest pain is usually dull, lateralized, and persistent. How it differs from cardiac, pleural, and chest wall causes.
Mesothelioma Early Warning Signs: What to Notice 20 to 50 Years After Asbestos Exposure
Mesothelioma takes decades to surface after asbestos exposure. The earliest signs are quiet. Here is what the primary clinical literature documents.
The Mesothelioma Symptom Timeline: From Latency to Late-Stage Progression
Mesothelioma unfolds over decades. Here is the chronological arc the primary clinical literature documents, from asbestos exposure to late-stage disease.
Pleural Effusion in Mesothelioma: Drainage, Recurrence, and What It Means for Prognosis
Most people with pleural mesothelioma present with fluid in the chest. What the clinical literature says about drainage, recurrence, and prognosis.
Stage 4 Mesothelioma: What to Expect and How Late-Stage Symptoms Are Managed
Clinical guide for families with someone in stage 4 mesothelioma: what AJCC staging means, what symptoms to expect, and how oncology teams manage them.
ADAO Sues EPA Over Missed Legacy Asbestos Rule Deadline
ADAO filed a federal lawsuit in April 2026 to compel EPA to propose a risk management rule for legacy asbestos. EPA missed a December 3, 2025 deadline.
Two Chemo-Combo Trials, Two Very Different Signals
DREAM3R stopped early and produced inconclusive data. BNT327 showed a 52% response rate in a small Phase 2. What each readout actually tells patients.
FDA Grants Orphan Drug Status to Orion's ODM-212
FDA grants orphan drug designation to Orion Pharma's ODM-212, an oral pan-TEAD inhibitor for mesothelioma, on April 20, 2026.
V Foundation Awards $1 Million Grant to UH Cancer Center for BAP1 Mesothelioma Research
V Foundation awards UH Cancer Center $1 million to fund a five-year study of mesothelioma in BAP1 gene mutation carriers, led by Carbone and Yang.
Asbestos Trust Funds for Louisiana Workers
How Louisiana shipyard, refinery, and longshore workers file asbestos trust claims. Key trusts for Avondale and Mississippi River corridor exposure.
Louisiana Mesothelioma Verdicts and Settlements: Chemical Corridor, Take-Home, and the Virile Share
Verified Louisiana mesothelioma verdicts: the $36.7M Walker case (affirmed at $35.75M), Pete v. Boland Marine, and a two-year prescriptive period under Act 423.
Louisiana Mesothelioma by the Numbers: Avondale, Refineries, and a One Year Deadline
Louisiana ranks among 7 states with female mesothelioma death rates above 6.0 per million. Avondale, refineries, and a one year filing window.
Asbestos Trust Funds for New Jersey Workers
How New Jersey shipyard, refinery, and Manville plant workers can file asbestos trust fund claims. Johns-Manville, W.R. Grace, and related trusts.
New Jersey Mesothelioma Verdicts and Settlements
Key New Jersey mesothelioma cases including Lanzo v. J&J, Barden v. J&J (reversed 2023), and Fowler v. Union Carbide ($2.38M, reinstated 2022).
Kroger, Contractor Pay $108K for Asbestos in Open Taylorville Store
Kroger and contractor SSI Services pay $108K to Illinois AG after leaving chipped asbestos floor tiles in public areas of an open Taylorville store.
New Jersey Mesothelioma by the Numbers: Shipyards, Refineries, and a Century of Exposure
New Jersey mesothelioma data: 114 diagnoses in 2021, 2,037 deaths 1999-2017, age-adjusted rate of 1.0 per 100,000. CDC and state court data.
Asbestos Trust Funds for Washington Workers
How Washington shipyard, paper mill, aluminum, and construction workers can file asbestos trust fund claims. Key trusts and process.
Wisconsin Supreme Court Upholds $26.5M Pabst Asbestos Verdict
Wisconsin Supreme Court affirms $26.5M verdict against Pabst for steamfitter Jerry Lorbiecki's mesothelioma death, rejecting its contractor defense.
Washington Mesothelioma Verdicts and Settlements
Washington mesothelioma outcomes: $13.5M Longview Fibre paper mill verdict, $16.2M Kotzerke default judgment, Budd v. Kaiser Gypsum, and 2025 appellate rulings.
Shipyards, Paper Mills, and Vermiculite: Washington Mesothelioma by the Numbers
Washington mesothelioma: 0.9 per 100K incidence (USCS 2021), top-two state death rate 1999-2015 (CDC MMWR), Puget Sound shipyards to Spokane vermiculite.
Asbestos Trust Funds for Alabama Workers
Alabama industrial history, state appellate precedent, and national 524(g) trusts that compensate Alabama workers exposed to asbestos.
Asbestos Trust Funds for California Workers
How California shipyard workers, refinery workers, and construction tradespeople can file asbestos trust fund claims. Key trusts and filing process.
Asbestos Trust Funds for Florida Workers
How Florida shipyard workers, military base personnel, and construction workers can file asbestos trust fund claims. Key trusts and process.
Asbestos Trust Funds for Georgia Workers
How Georgia shipyard workers, paper mill employees, and construction tradespeople can file asbestos trust fund claims. Key trusts and filing process.
Asbestos Trust Funds for Indiana Workers
How Indiana steelworkers, auto workers, and power plant employees can file asbestos trust fund claims. Key trusts and filing process.
Asbestos Trust Funds for Iowa Workers
How Iowa manufacturing, meatpacking, and agricultural equipment workers can file asbestos trust fund claims. Key trusts and filing process.
Asbestos Trust Funds for Michigan Workers
How Michigan auto workers and tradespeople file asbestos trust claims. Wayne County master docket, MI statute of limitations, Federal-Mogul Trust.
Asbestos Trust Funds for Missouri Workers
How Missouri manufacturing workers, mechanics, and railroad employees can file asbestos trust fund claims. Key trusts and eligibility.
Asbestos Trust Funds for New York Workers
How New York shipyard workers, construction tradespeople, and 9/11 responders can file asbestos trust fund claims. Key trusts and filing process.
Asbestos Trust Funds for Ohio Workers
How Ohio steelworkers, auto workers, and pipefitters can file asbestos trust fund claims. Key trusts, eligibility, and filing process.
Asbestos Trust Funds for Pennsylvania Workers
How Pennsylvania steel mill workers, shipyard workers, and construction tradespeople can file asbestos trust fund claims. Key trusts and process.
Asbestos Trust Funds for Tennessee Workers
How Tennessee chemical plant workers, Oak Ridge employees, and manufacturing workers can file asbestos trust fund claims.
Asbestos Trust Funds for Wisconsin Workers
How Wisconsin paper mill workers, manufacturers, and shipyard workers can file asbestos trust fund claims. Key trusts and filing process.
Alabama Mesothelioma Verdicts and Settlements
Alabama mesothelioma litigation, from Birmingham steel to the Mobile shipyards. Key cases, filing deadlines, and what the verified record actually shows.
California Mesothelioma Verdicts and Settlements
Two California mesothelioma outcomes confirmed by primary sources: the $33.4M Stephenson v. Mole-Richardson verdict and the $51M Chapman v. Avon judgment.
Florida Mesothelioma Verdicts and Settlements
Documented Florida mesothelioma verdicts, from J&J talc to secondhand brake dust, with verified Fla. Stat. § 95.11 filing deadlines and appellate status notes.
Georgia Mesothelioma Verdicts and Settlements
Verified Georgia mesothelioma verdicts, causation doctrine, and filing deadlines, from the Scapa Dryer Fabrics reversal to Georgia-Pacific asbestos litigation.
Asbestos Trust Funds for Illinois Workers
Asbestos trust funds for Illinois workers: Madison and St. Clair venue history, IL Supreme Court precedent, and 2-year SOL under 735 ILCS 5/13-202.
Indiana Mesothelioma Verdicts and Settlements
Indiana mesothelioma litigation, case law on the statute of repose, and how steel mill and auto plant exposure histories shape outcomes.
Iowa Mesothelioma Verdicts and Settlements
Iowa mesothelioma litigation, including the Kinseth v. Weil-McLain $6.5M verdict reversed on appeal and the 2022 Beverage v. Alcoa ruling on Chapter 686B scope.
Michigan Mesothelioma Verdicts and Settlements
Michigan mesothelioma litigation, from Great Lakes shipping to Wayne County. Key cases, the discovery-rule filing deadline, and what the verified record shows.
$20 Million and Counting: Missouri Mesothelioma Verdicts
St. Louis leads Missouri in asbestos jury awards. Key verdicts and what they mean for Missouri families with mesothelioma.
New York Mesothelioma Verdicts and Settlements
Key mesothelioma verdicts and settlements in New York, including the $117M Durbec WTC verdict. NYCAL leads the nation in asbestos case volume.
$27.5 Million and Counting: Ohio Mesothelioma Verdicts
Cuyahoga County leads Ohio in mesothelioma jury awards. Key verdicts and what they mean for Ohio families pursuing asbestos claims.
Pennsylvania Mesothelioma Verdicts and Settlements
Pennsylvania mesothelioma verdicts and 2025 developments: the $3.8M Chirdon verdict, the Herold ruling, and Philadelphia asbestos litigation.
Tennessee Mesothelioma Verdicts and Settlements
Tennessee mesothelioma verdicts: Stockton v. Ford, Davis v. Ameron, the Satterfield take-home precedent, and the one-year filing deadline.
Asbestos Trust Funds for Virginia Shipyard Workers and Navy Veterans
How Virginia shipyard workers, Navy veterans, and their families can file asbestos trust fund claims, including the C.E. Thurston & Sons Trust.
Wisconsin Mesothelioma Verdicts and Settlements
Key mesothelioma verdicts and settlement outcomes in Wisconsin, including the Pabst Brewing safe-place ruling and the Krentz take-home exposure verdict.
Shipyards and Paper Mills: Georgia Asbestos Exposure Legacy
How Savannah shipyards, paper mills, and Atlanta manufacturing exposed generations of Georgia workers to asbestos.
Birmingham Steel, Mobile Ships: Alabama's Asbestos Legacy
How steel mills in Birmingham and shipyards in Mobile exposed generations of Alabama workers and families to asbestos.
Chicago Steel Mills: The Southeast Side Asbestos Legacy
How U.S. Steel South Works, Wisconsin Steel, and Republic Steel exposed generations of Chicago workers and families to asbestos.
Cleveland's Rust Belt Legacy: Steel Mills and Auto Plants That Exposed Thousands
How Republic Steel, LTV Steel, and auto plants across Cleveland and Toledo exposed generations of Ohio workers to asbestos.
Manufacturing and Meatpacking: Iowa Asbestos Exposure Legacy
How Des Moines manufacturing, Cedar Rapids industry, and Iowa meatpacking plants exposed generations of workers to asbestos.
Detroit's Auto Plants: The Asbestos Legacy of Ford, GM, and Chrysler
How decades of asbestos use in Michigan auto plants exposed generations of workers and families to deadly fibers.
Steel Mills and Auto Plants: Indiana Asbestos Exposure History
How Gary steel mills, Indianapolis auto plants, and Indiana power facilities exposed generations of workers to asbestos.
$45 Million and Counting: Illinois Mesothelioma Verdicts
Cook County leads the nation in mesothelioma jury awards. Key verdicts from 2023 to 2024 and what they mean for Illinois families.
Shipyards and Bases: Florida Asbestos Exposure in Jacksonville, Tampa, and Beyond
How Jacksonville shipyards, Pensacola NAS, Patrick AFB, and Tampa ship repair exposed generations of Florida workers to asbestos.
Shipyards, Refineries, and Geology: California Asbestos Exposure Legacy
How Hunters Point, Long Beach shipyards, Bay Area refineries, and naturally occurring asbestos in 42 counties exposed generations of California workers.
Paper Mills and Factories: Wisconsin Asbestos Exposure Legacy
How Fox River Valley paper mills and Milwaukee manufacturing exposed generations of Wisconsin workers to asbestos.
Chemical Plants and Oak Ridge: Tennessee Asbestos Exposure Legacy
How chemical plants, Oak Ridge nuclear facilities, and manufacturing exposed generations of Tennessee workers to asbestos.
Brooklyn Navy Yard and the WTC: New York City Asbestos Exposure Legacy
How the Brooklyn Navy Yard, World Trade Center collapse, and NYC construction trades exposed generations of New Yorkers to asbestos.
Steel Mills and Shipyards: Pennsylvania Asbestos Exposure Legacy
How Bethlehem Steel, Philadelphia Navy Yard, and Pittsburgh mills exposed generations of Pennsylvania workers to asbestos.
St. Louis Manufacturing: A Century of Asbestos Exposure
How manufacturing, lead smelting, and railroads exposed generations of St. Louis workers and families to asbestos.
Virginia Mesothelioma Verdicts and Settlements
Key Virginia mesothelioma verdicts from the $6.45M Parker case at Norfolk Naval Shipyard to the $17M Coulbourn verdict and the reversed Minton judgment.
Alabama Mesothelioma by the Numbers: Birmingham Steel and Mobile Shipyards
Alabama has one of the Southeast's highest mesothelioma death rates. CDC data on cases, industries, and exposure across Birmingham and Mobile.
Most Cases in the Country: California Mesothelioma by the Numbers
California leads the US in total mesothelioma cases. CDC data on diagnoses, deaths, and exposure across LA, San Francisco, and 42 natural asbestos counties.
Second in the Nation (Cumulative): Florida Mesothelioma by the Numbers
Florida ranks second in cumulative mesothelioma cases. 5,619 cases (1999-2022), 3,300+ deaths, exposure across Tampa, Jacksonville, Miami.
Georgia Mesothelioma Data: 651 Deaths Recorded 1999-2015 (CDC)
CDC data on Georgia mesothelioma cases, deaths, and asbestos exposure across Atlanta, Savannah, and Augusta. County-level breakdown and state rankings.
Illinois Mesothelioma Statistics 2026: Cook County Verdicts, Industries, and Deadlines
Three Cook County verdicts totaling $115.75M, confirmed exposure industries, and the two-year filing deadline for Illinois mesothelioma claims.
Indiana Mesothelioma Rates: Steel Belt Legacy in the Data
CDC data on Indiana mesothelioma deaths, cases by county, and exposure across Gary steel mills, auto plants, and power facilities.
Twice the National Average: Iowa Mesothelioma by the Numbers
Iowa mesothelioma rates are double the US average. CDC data on 525 deaths and the industries driving elevated rates across manufacturing and meatpacking.
2,460 Diagnoses: Michigan Mesothelioma by the Numbers
Michigan ranks fourth nationally for mesothelioma rates. CDC data on cases, deaths, and exposure across Wayne, Kent, and Genesee counties.
Missouri Mesothelioma by the Numbers: St. Louis and Kansas City
Missouri ranks among the top states for asbestos deaths. CDC data on cases, industries, and exposure across St. Louis and Kansas City.
New York Mesothelioma Cases and Statistics: 2026 Update
CDC data on New York mesothelioma cases, deaths, and asbestos exposure across NYC, Buffalo, Albany, and Syracuse. Top-5 state by case volume.
Ohio Mesothelioma Statistics 2026: Cases, Deaths, and Industrial Exposure
Ohio averages 110 new mesothelioma cases and 103 deaths per year (ODH, 2018-2022). CDC data on incidence, Cuyahoga litigation history, and state law deadlines.
Second Highest Rate in the Nation: Pennsylvania Mesothelioma by the Numbers
Pennsylvania ranks 2nd nationally for mesothelioma at 1.22 per 100,000. CDC data: 4,627 diagnoses 1999-2022. Two-year statute of limitations.
One-Year Filing Deadline: Tennessee Mesothelioma by the Numbers
Tennessee ranks 19th in mesothelioma cases with 62 annual diagnoses. CDC data on deaths, exposure across the state, and the shortest SOL in the nation.
Virginia Mesothelioma by the Numbers: A Shipyard-State Profile
Virginia mesothelioma statistics: 82 annual diagnoses, 0.7 per 100K rate, and exposure concentrated in Newport News and Norfolk Naval shipyards.
Highest Rate in the Nation: Wisconsin Mesothelioma by the Numbers
Wisconsin leads the US in per capita mesothelioma. CDC data on cases, deaths, and exposure across Milwaukee, Fox Valley, and paper mill counties.
Asbestos Product Recalls 2026: A Running Global Tally
Every asbestos-contaminated product recall in 2026, tracked by country, retailer, and product type. Why the U.S. has been slow to act.
Asbestos Trust Funds for Maryland Workers
How Maryland shipyard, steel, and insulation workers file claims against the Porter Hayden, Wallace & Gale, and other asbestos trusts tied to the state.
Why Immunotherapy Works Differently in Peritoneal Mesothelioma
Nature study finds tumor location shapes immune environment, explaining why checkpoint therapy is less effective in peritoneal disease.
Maryland Mesothelioma Verdicts and Settlements
Maryland mesothelioma case outcomes: the $1.56B Cherie Craft talc verdict, $14.5M Busch steamfitter case, and Dixon take-home Ford brake verdict.
Peritoneal vs Pleural Mesothelioma: A 2026 Data Comparison
Side-by-side comparison of pleural and peritoneal mesothelioma: incidence, survival, treatment, and immune response, with 2026 data.
$850,000 Settlement for Families After Daycare Asbestos Exposure
Seventeen families reach settlement with Montana after children exposed to asbestos at University of Montana daycare facilities in 2018.
Maryland Mesothelioma by the Numbers: Sparrows Point, Shipyards, and Baltimore
Maryland mesothelioma data: 916 deaths 1999-2017, Sparrows Point exposure history, Baltimore County asbestos burden, and where cases cluster.
Six Years of Mesothelioma Immunotherapy: From First Approval to 2026
From the 2020 CheckMate-743 approval to the 2025 BNT327 results, every major mesothelioma immunotherapy milestone in one timeline.
Asbestos in American Schools: What the 2026 Data Shows
How many U.S. schools still contain asbestos, what AHERA requires, and what parents can demand from their districts.
Blood Clot Biomarkers Could Predict Risk After Mesothelioma Surgery
Proteomics study identifies plasma protein markers that may predict which people with mesothelioma are at risk of blood clots after surgery.
Cohesin Gene Mutations Linked to Mesothelioma Recurrence After Surgery
Genomic study finds SMC3 and SMC1A mutations in multicystic peritoneal mesothelioma predict disease recurrence after cytoreductive surgery and HIPEC.
Asbestos in Children's Sand Products: Eight Countries, Zero US Action
Tremolite asbestos in play sand has triggered recalls across eight countries since late 2025. US regulators have not tested or recalled any products.
Asbestos Trust Funds for Massachusetts Workers
How Massachusetts shipyard workers, textile mill workers, and construction tradespeople can file asbestos trust fund claims. Key trusts and process.
Asbestos Trust Funds for Minnesota Workers
How Minnesota taconite miners, Conwed fiberboard workers, and building tradespeople can file asbestos trust fund claims. Key trusts and process.
First ROS1 Fusion in Peritoneal Mesothelioma Responds to Crizotinib
First ROS1 gene fusion found in peritoneal mesothelioma. Patient achieved six months on crizotinib after immunotherapy failed.
Massachusetts Mesothelioma Verdicts and Settlements
Massachusetts mesothelioma verdicts, including the $83M Lapointe v. AMACO Middlesex Superior verdict and the $42.6M Lovell talc verdict.
The Mesothelioma Treatment Landscape in 2026
Every major first-line, second-line, and investigational treatment for mesothelioma in 2026, with response rates, survival data, and trial status.
Minnesota Mesothelioma Verdicts and Settlements
Minnesota mesothelioma verdicts: the $65.5M Ramsey County talc verdict against J&J, Conwed ceiling tile cases, and Iron Range taconite claims.
Shipyards, Mills, and Mesothelioma: Massachusetts by the Numbers
Massachusetts CDC data on mesothelioma: 2,004 diagnoses and 1,642 deaths from 1999 to 2020, plus shipyard and textile mill exposure history.
Minnesota Mesothelioma by the Numbers: Taconite, Fiberboard, and the Iron Range
Minnesota mesothelioma statistics: CDC data, the Taconite Workers Health Study on 80 Iron Range cases, and the Conwed Cloquet fiberboard plant cohort.
First PITAC Procedure for Mesothelioma Performed in North America
A surgeon has performed the first pressurized aerosol chemotherapy (PITAC) for mesothelioma in North America, bringing a European innovation to U.S. patients.
Asbestos Trust Funds for Connecticut Workers
How Connecticut submarine builders, brake plant workers, and helicopter plant workers can file asbestos trust fund claims. Key trusts and process.
MSK Study: Mesothelioma Rising in People Under 50, BAP1 Mutations a Key Factor
Memorial Sloan Kettering study of 273 younger patients finds BAP1 gene mutations, not just asbestos, drive mesothelioma in adults under 50.
Asbestos Trust Funds for Oregon Workers
How Oregon shipyard, mill, and construction workers can file asbestos trust fund claims. Key trusts, eligibility, and the filing process explained.
TGF-β Combo Therapy Cuts Mesothelioma Tumor Growth by 70% in Lab Models
A 2026 study in Scientific Reports shows combined TGF-β inhibition reduced mesothelioma cell growth by up to 70% in preclinical models.
Connecticut Mesothelioma Verdicts and Settlements
Connecticut mesothelioma verdicts: $25M Plotkin J&J talc award, $22.5M Barone Vanderbilt verdict, and key jurisdictional rules from Bridgeport Superior Court.
Oregon Mesothelioma Verdicts and Settlements
Key Oregon mesothelioma verdicts, from the $34.2M John Crane Portland shipyard case to the $260M J&J talc award and the Hoff and Sprague decisions.
Connecticut Mesothelioma by the Numbers: Submarines, Brake Plants, and Talc
Connecticut mesothelioma: 715 deaths 1999-2017, Electric Boat in Groton, Raymark Superfund in Stratford, and the landmark Selikoff study.
Oregon Mesothelioma by the Numbers: A Pacific Northwest Industrial Legacy
Oregon ranks among the top seven states for mesothelioma mortality in women. CDC data, Portland shipyards, and the exposure sites driving Oregon cases.
Which Asbestos Trust Funds Apply to Texas Workers?
Texas refinery, shipyard, and plant workers may qualify for multiple asbestos trust funds. How claims work and what to expect.
Galveston Shipyard Workers and Mesothelioma: What the Navy Records Show
Galveston and Texas City shipyards exposed thousands to asbestos during WWII and beyond. Data on workers, claims, and outcomes.
Beaumont to Texas City: Inside America's Asbestos Corridor
The Beaumont-Port Arthur-Texas City industrial belt concentrated more refineries and petrochemical plants than almost anywhere in North America.
Texas Asbestos Verdicts and Settlements: What the Record Shows
Texas asbestos verdicts: the $178.5M Cimino trust resolution and Rogers v. Goodyear ($18.6M reduced to $1.15M on appeal), plus SOL and Chapter 90/41 caps.
524 Asbestos Deaths in Houston: Inside the Gulf Coast's Deadliest Industry
Houston leads Texas in asbestos deaths. A data analysis of the refineries, plants, and shipyards behind the toll.
4,467 Diagnoses: Texas Mesothelioma by the Numbers
Texas ranks fifth in US mesothelioma diagnoses. CDC data on cases, deaths, and exposure by city and industry.
Canada Recalls Children's Craft Sand Over Asbestos
Health Canada recalled children's craft sand and candle kits after testing found asbestos fibers. Part of a global wave spanning seven countries.
$30B in Trust Funds: How Much Has Been Paid Out
Data analysis of 60+ asbestos trust funds: total payouts, payment percentages, average claim values, and how the system works.
J&J $950M Punitive Damages Overturned in Talc Case
A Los Angeles judge struck $950M in punitive damages from a $966M J&J talc verdict, leaving $16M in compensatory damages for the family of Mae Moore.
Mesothelioma Survival Rates by Treatment Type
Survival rates for mesothelioma by treatment: surgery, chemotherapy, immunotherapy, multimodal, and HIPEC. Data from SEER, NCI, and clinical trials.
8 Mesothelioma Trials Compared: Results Side by Side
Side by side results from CheckMate-743, KEYNOTE-483, ATOMIC-Meso, DREAM3R, CONFIRM, MARS 2, DENIM, and Hopkins periop.
Asbestos in Craft Sand Closes 450+ Schools in ANZ
Tremolite asbestos found in children's colored sand from China prompts school shutdowns, product recalls, and cleanup operations.
$24.6M Default Judgment in Gold Bond Talc Case
Los Angeles court enters default judgment against Martin Himmel Inc. after the former Gold Bond owner lost counsel and stopped participating.
Pelvic Mesothelioma Shrinks 83% With Immunotherapy
Frontiers in Oncology case study shows toripalimab plus chemotherapy produced major tumor reduction in rare pelvic mesothelioma.
FDA and Talc: Testing Rule Proposed, Then Withdrawn
The FDA found asbestos in J&J Baby Powder in 2019, proposed mandatory testing in 2024, then withdrew the rule in 2025. No federal testing requirement exists.
What J&J Knew: Asbestos in Talc Since the 1970s
Internal documents show J&J found asbestos in talc in 1972, paid to suppress findings, and blocked FDA warnings. A timeline of corporate concealment.
Talc Mesothelioma Verdicts: Billions in Jury Awards
From $1.56 billion to hundreds of millions, juries are awarding massive verdicts in talc mesothelioma cases. Complete tracking of every major award.
Talc and Mesothelioma in Women: The Hidden Exposure
74.7% of talc-related mesothelioma cases are women. Cosmetic talc is a primary asbestos exposure pathway for women without occupational history.
J&J Talc Bankruptcy: Three Failed Attempts
Johnson & Johnson tried three times to resolve 90,000+ talc lawsuits through subsidiary bankruptcy. All three were rejected. Here is what happened.
Talc Ovarian Cancer Lawsuits: 90,000+ Cases
Over 90,000 talcum powder lawsuits filed against J&J. 67,000+ in federal MDL. New cases still being accepted. Here is where things stand.
Who's at Risk: Talc and Ovarian Cancer Risk Factors
African American women face 40%+ increased risk. Frequency, duration, and type of talc use all affect ovarian cancer risk. Understand your exposure.
Scientific Evidence: How Talc Causes Ovarian Cancer
IARC classifies talc as probably carcinogenic. Pooled meta-analyses, NIH cohort data, and 50+ years of research examine genital talc and ovarian cancer.
Talc and Ovarian Cancer Timeline (1971-2026)
From talc in ovarian tumors (1971) to billion-dollar verdicts (2025). The complete chronology of science, J&J knowledge, and legal action.
Ovarian Cancer Symptoms After Talc Exposure
Ovarian cancer from talc use often goes undetected. Learn the warning signs, when to see a doctor, and why talc exposure history matters for diagnosis.
Talc Ovarian Cancer Verdicts: Timeline of Major Jury Awards
Timeline of talcum powder jury verdicts from 2013 through 2026, including post-appeal status for every major ovarian cancer and mesothelioma award.
Durvalumab Plus Chemo Doubles Meso Survival
Phase II PrE0505 trial shows durvalumab with pemetrexed-cisplatin yields 20.4-month median survival in unresectable pleural mesothelioma.
UK Trials Proton Beam Therapy for Mesothelioma
Phase III HIT-Meso trial compares proton beam therapy to surveillance across 23 UK centers, recruiting 148 people with pleural mesothelioma.
$1.56B Verdict Against J&J in Talc Mesothelioma Case
Maryland jury orders J&J to pay $1.56 billion after finding the company concealed asbestos risks in talc baby powder. J&J plans appeal.
Asbestos in Drinking Water: 5x Federal Limit in PA
DEP confirms asbestos contamination tripled to 33 million fibers per liter in Brockway Borough water from deteriorating 1950s pipes.
Hawaii Identifies L-BAM, Treatable Mesothelioma
UH Cancer Center researchers discover a genetic mesothelioma variant caused by BAP1 mutations, not asbestos, that responds to standard treatment.
Mesothelioma Rates by State: 2026 Rankings
Data analysis of mesothelioma rates across all 50 states, ranked by total cases and per capita rates. CDC data through 2022.
Mesothelioma Risk by Occupation: 2026 Data
Occupational mesothelioma risk, ranked by exposure level. Insulation, shipyard, and pipefitting trades face the highest rates.
Veterans and Mesothelioma: Risk by Military Branch
Veterans account for a significant share of U.S. mesothelioma cases. Navy, Marines, Army, Air Force, and Coast Guard risk data with VA benefits breakdown.
CheckMate-743 at Five Years: 14% Still Alive
Five-year data from CheckMate-743 shows 14% survival with nivolumab plus ipilimumab vs 6% with chemotherapy. Non-epithelioid benefit is striking.
Banjima Launch $1.5B Asbestos Claim Over Wittenoom
Banjima traditional owners filed a $1.5B Federal Court claim against Western Australia over decades of asbestos contamination at Wittenoom.
Talc Claimants Challenge Revlon Bankruptcy Ruling
People with mesothelioma and ovarian cancer argue Revlon bypassed asbestos trust requirements to avoid paying future talc claims in bankruptcy.
CA Court Rejects San Diego Workers Asbestos Suit
A California appeals court ruled 40 San Diego city employees exposed to asbestos during 2018 renovations must seek damages through workers' comp.
UK Recalls 21+ Toys Over Asbestos in Sand Products
UK safety officials have recalled 21+ children's toys containing asbestos. Full product list with brands, retailers, and product codes.
DHS Workers Exposed to Asbestos at DC Demo Site
Federal employees at DHS headquarters say demolition crews wear full protective gear while office workers nearby go without masks or monitoring.
WA Contractor Fined $200K for Asbestos Violations
Seattle Environmental Services faces 10 willful violations after three workers removed asbestos without respirators at a Bellevue home.
Vanderbilt Minerals Files Bankruptcy Over Talc
The Connecticut mining company blamed $117M in talc litigation costs. It plans to sell assets for $50M while 1,400+ pending cases are frozen.
DREAM3R: Durvalumab Plus Chemo Falls Short
DREAM3R Phase 3 trial of durvalumab plus chemotherapy for pleural mesothelioma stopped early due to enrollment challenges. A 58% response rate, but no proof.
Smith Law Firm Sues Funders in Talc Cases
Mississippi talc firm representing 11,500 claimants accuses Ellington Financial, ICG, and Stifel of withholding $30M to seize case fees.
Philly Jury Finds J&J Liable in Talc Case, $250K
Philadelphia County jury awards $250,000 to the estate of Gayle Emerson in the city's first talc plaintiff victory after years of bankruptcy delays.
Baylor-Duke NEMO Trial Tests Immuno Before Surgery
NEMO trial at Baylor and Duke is recruiting people with operable pleural mesothelioma to test chemoimmunotherapy before surgery.
9th Circuit Overturns $8M BNSF Libby Asbestos Verdict
The 9th Circuit reversed the $8M verdict against BNSF Railway, ruling the company is immune from strict liability as a common carrier under Montana law.
Blood Test Predicts Immunotherapy Response in Meso
Georgetown-Hopkins Phase 2 trial shows ctDNA blood test predicts which people with mesothelioma benefit from immunotherapy before surgery.
$51M Avon Talc Verdict Upheld in Mesothelioma Case
California appeals court upholds $51M verdict against Avon for asbestos in talc powders. Jury found company knew of risks since the 1970s.
$34.2M Verdict Against John Crane in Oregon Shipyard Case
Portland jury awards $34.2M to shipyard worker for mesothelioma caused by John Crane asbestos gaskets. Internal docs showed company knew risks.
Mount Sinai P/D Surgery: Zero Mortality in Study
Mount Sinai reports zero perioperative mortality for pleurectomy/decortication in mesothelioma, challenging MARS2 trial skepticism.
UCSF Proposes First Peritoneal Meso Staging System
Dr. Mohamed Adam's survival tree model uses mitotic rate, PCI, and histology to stage peritoneal mesothelioma and guide CRS-HIPEC decisions.
$18M Verdict in Florida Brake Dust Mesothelioma Lawsuit
Florida jury awards $18 million to Denise Cook in brake dust mesothelioma lawsuit after secondary asbestos exposure from father's auto shop.
Beasley Allen Disqualified From NJ Talc MDL
NJ appeals court disqualifies Beasley Allen from 3,600 talc cases after former J&J lawyer collaborated with firm on adverse settlement strategy.
Asbestos Pipe Maker Sues Plaintiff Law Firm
J-M Manufacturing filed a RICO lawsuit against the Gori law firm. Similar tactics by Garlock in 2014 were dropped. Here's what claimants should know.
J&J Talc Lawsuits: Verdicts and Settlements (2026)
Complete guide to J&J talc lawsuits, including $15B+ in verdicts, bankruptcy attempts, mesothelioma claims, and how to file a case. Updated January 2026.
Checkpoint Inhibitors for Mesothelioma: FDA Options
FDA-approved nivolumab plus ipilimumab improves mesothelioma survival. Learn how checkpoint inhibitors work, side effects, and who benefits.
Genetic Testing for Mesothelioma: What to Know
Genetic testing for mesothelioma including BAP1, CDKN2A, and NGS panels. How results guide treatment decisions and clinical trial eligibility.
Rare Mesothelioma Cell Types: Variants and Care
Rare mesothelioma cell types: desmoplastic, lymphohistiocytoid, deciduoid, and WDPM variants. Diagnosis challenges and prognosis.
Targeted Therapy for Mesothelioma: 2026 Guide
Targeted therapy options for mesothelioma including BAP1, NF2, and TEAD inhibitors. Current clinical trials and who may benefit.
$8M Verdict: J&J Talc Mesothelioma Case in Massachusetts
Suffolk County jury awards $8 million to Janice Paluzzi, 84, who developed mesothelioma after using J&J Baby Powder for 20+ years.
ADI-PEG20 Phase 3 Trial Shows Promise: ATOMIC-Meso Results
ATOMIC-Meso Phase 3 trial shows ADI-PEG20 plus chemotherapy improves survival in pleural mesothelioma. Analysis of this arginine-depleting therapy.
Ikena Halts IK-930 TEAD Inhibitor Program
Ikena discontinued IK-930 in May 2024 after disappointing Phase 1 data in NF2-mutated tumors including mesothelioma. Other TEAD inhibitors advance.
J&J Texas Two-Step Fraud Lawsuit Dismissed
A federal judge dismissed a fraud suit by five women with cancer alleging J&J used bankruptcy to shield billions. The 67,000+ talc cases remain pending.
UV1 Vaccine Gets FDA Fast Track for Mesothelioma
FDA grants Fast Track to UV1 telomerase vaccine for mesothelioma. Combined with immunotherapy, UV1 showed 64% response rate in trials.
Atezolizumab Trial: Phase 1 Study for Mesothelioma
Cancer Research UK PHASE1/PHASE2 clinical trial testing atezolizumab (Tecentriq) for people with mesothelioma. Trial NCT05944237 is now recruiting.
Atezolizumab Phase 3 Trial for Pleural Mesothelioma
PHASE3 clinical trial testing atezolizumab (Tecentriq) for mesothelioma. Trial NCT04996017 is recruiting.
Atezolizumab Phase 1 Trial for Pleural Mesothelioma
University Hospital, Antwerp PHASE1/PHASE2 clinical trial testing atezolizumab (Tecentriq) for people with mesothelioma. Trial NCT05765084 is now recruiting.
A2 Bio BASECAMP-1 Screening Study (NCT04981119)
A2 Biotherapeutics Inc. observational prescreening study collecting cells from solid tumor patients for future CAR-T manufacturing. NCT04981119.
A2 Bio EVEREST-2 CAR-T Phase 1/2 Trial (NCT06051695)
A2 Biotherapeutics EVEREST-2 Phase 1/2 trial of A2B694, a logic-gated Tmod CAR-T targeting mesothelin-positive solid tumors including mesothelioma.
UTC CAR-T Phase 1 Trial (NCT06256055)
UTC Therapeutics Phase 1 trial of UCMYM802, a circular-mRNA anti-mesothelin CAR-T for mesothelin-positive solid tumors including mesothelioma.
NCI TNhYP218 CAR-T Phase 1 Trial (NCT06885697)
National Cancer Institute Phase 1 trial of TNhYP218, an anti-mesothelin CAR-T, for mesothelin-expressing solid tumors including mesothelioma.
CAR-T Trial: Phase 1 Study for Pleural Mesothelioma
Suzhou Maximum Bio-tech Co. Ltd. Phase 1 trial of MT027, a B7-H3 targeted CAR-T delivered intrapleurally for pleural malignant tumors. NCT06726564.
Immunotherapy Trial: Phase 1 Study for Mesothelioma
Baylor College of Medicine PHASE1/PHASE2 clinical trial testing immunotherapy for people with mesothelioma. Trial NCT05932199 is now recruiting.
NCI HIPEC Phase 1 Trial (NCT04847063)
PHASE1 clinical trial testing HIPEC (heated intraperitoneal chemotherapy) for mesothelioma. Trial NCT04847063 is recruiting.
MSK HIPEC Phase 2 Trial (NCT06057935)
Phase 2 trial (NCT06057935) for peritoneal mesothelioma: cytoreductive surgery plus HIPEC, then intraperitoneal or IV chemotherapy. Enrolling at MSK New York.
NCI HIPEC Phase 2 Trial (NCT05001880)
PHASE2 clinical trial testing HIPEC (heated intraperitoneal chemotherapy) for mesothelioma. Trial NCT05001880 is recruiting.
TIL Cell Therapy Phase 2 Trial (NCT03935893)
UPMC Hillman Cancer Center Phase 2 clinical trial testing autologous TIL cell therapy for people with mesothelioma. Trial NCT03935893 is recruiting.
BWH MAGIC AKI Phase 2 Trial (NCT05730816)
Brigham and Women's Hospital Phase 2 trial testing IV magnesium to prevent kidney injury during HIOC cisplatin surgery for mesothelioma (NCT05730816).
MSK Sacituzumab Govitecan Phase 2 Trial (NCT06477419)
Memorial Sloan Kettering Phase 2 trial of sacituzumab govitecan for previously treated diffuse pleural mesothelioma (NCT06477419) is recruiting.
NCI FAPI-74 PET Imaging Phase 2 Trial (NCT06503146)
National Cancer Institute Phase 2 imaging trial evaluating [18F]FAPI-74 PET scans for cancer detection, including mesothelioma (NCT06503146).
Mesothelioma Clinical Trials Recruiting in 2026
Approximately 90 mesothelioma trials are recruiting in 2026. We profile active CAR-T, CAR-NK, bispecific, and surgery trials from ClinicalTrials.gov.
Nivolumab + Ipilimumab Phase 2 Trial for Mesothelioma
Alliance phase 2 trial testing nivolumab + ipilimumab for mesothelioma. NCT05647265 is now recruiting patients.
Photodynamic Therapy + Nivolumab Phase 2 Trial (NCT04400539)
Phase 2 trial (NCT04400539) at University Hospital Lille testing intrapleural photodynamic therapy followed by nivolumab for mesothelioma. Now recruiting.
Nivolumab + Ipilimumab Phase 1/2 Trial (NCT07121374)
University Hospital, Antwerp PHASE1/PHASE2 clinical trial testing nivolumab plus ipilimumab for people with mesothelioma. Trial NCT07121374 is now recruiting.
VM Oncology Pembrolizumab Phase 1/2 (NCT03556228)
VM Oncology, LLC PHASE1/PHASE2 clinical trial testing pembrolizumab (Keytruda) for people with mesothelioma. Trial NCT03556228 is now recruiting.
MSK Pembrolizumab Phase 1 Trial (NCT04897022)
Phase 1 trial (NCT04897022) at Memorial Sloan Kettering testing pembrolizumab (Keytruda) for mesothelioma. Active, not recruiting.
Pembrolizumab, Chemo and Lenvatinib Phase 2 Trial for Pleural Mesothelioma
Phase 2 trial NCT06318286 (PENINSULA) at Hyogo Medical University: pembrolizumab plus platinum chemotherapy and lenvatinib for pleural mesothelioma. Recruiting.
Volrustomig (MEDI5752) Phase 3 Trial in Pleural Mesothelioma (NCT06097728)
AstraZeneca's volrustomig (MEDI5752), a PD-1/CTLA-4 bispecific antibody, in a global Phase 3 trial vs platinum-pemetrexed or nivolumab + ipilimumab.
Hopkins: Immunotherapy + Surgery Extends Survival
Johns Hopkins trial shows pre/post-surgery nivolumab + ipilimumab safe for operable mesothelioma, with 28.6-month median survival.
$20M Verdict Against J&J in Florida Mesothelioma Case
Florida jury awards $20 million to a man with mesothelioma, finding Johnson & Johnson liable for asbestos-contaminated talc powder exposure.
The Asbestos Cover-Up: What the Industry Knew in 1930
Company memos reveal asbestos manufacturers knew their products were killing workers decades before warning anyone. The paper trail of corporate deception.
Your Mechanic May Be Breathing Asbestos Right Now
Millions of aftermarket brake pads still contain asbestos. Every brake job releases fibers. Why auto mechanics face a hidden cancer risk.
About 2,500 Americans Die From Mesothelioma Each Year
Who is dying from mesothelioma in America: veterans, construction workers, and people who never worked with asbestos. The numbers behind the epidemic.
The Hidden Danger in Your Ceiling
Millions of homes have popcorn ceilings that may contain asbestos. What homeowners must know before scraping or renovating.
Advocates Sue for East Wing Asbestos Records
ADAO sues for asbestos records from Trump's White House East Wing demolition. No abatement paperwork filed with D.C. regulators despite rapid 3-day teardown.
New Review Maps BAP1 Loss in Mesothelioma
New Oncogene review maps BAP1 loss mechanisms in mesothelioma. 65% of cases involve BAP1 inactivation; EZH2 inhibitors emerge as potential targeted therapy.
UK Recalls Children's Play Sand After Asbestos Found
Hobbycraft withdraws colored craft sand from UK stores after a parent's lab test confirmed tremolite asbestos in three colors. Government urges formal recall.
Talcum Powder Crisis By the Numbers
The talc crisis by the numbers: about 90,000 lawsuits, $10B+ in verdicts, and decades of corporate knowledge. The data tells the story.
UK, EU Split on Talc Cancer Classification
UK declines to classify talc as a carcinogen while EU recommends Category 1B classification, creating regulatory uncertainty for cosmetics.
$42.6M J&J Talc Verdict in Massachusetts
Massachusetts jury awards $42.6 million to Paul Lovell's family in mesothelioma verdict against Johnson & Johnson over talc powder contamination.
Welders and Asbestos Exposure Risks
Welders faced asbestos exposure from welding blankets, electrode coatings, and work near asbestos insulation. Learn about exposure sources and legal options.
Montana Windstorm Scatters School Asbestos
A December windstorm ripped the roof off a Park City, Montana school gym, spreading asbestos insulation into 15 homes. EPA is conducting free cleanup.
Cell Therapy Shrinks Tumors in 63%
A new cell therapy achieved tumor shrinkage in 63% of advanced mesothelioma patients. More than double typical response rates.
Navy Veterans and Asbestos Risks
Navy veterans faced extensive asbestos exposure aboard ships and at naval shipyards. Learn about exposure sources, VA benefits, and legal options.
Cassiar: The Town That Asbestos Built
For 40 years, Cassiar, BC mined chrysotile asbestos while 50,000 residents came and went. Now, former residents say they were never warned.
Vi-Jon Talc Mesothelioma Case Settles in California
A California talc mesothelioma trial captioned Maricich Jr. et al. v. Chattem, Inc. settled January 21, 2026 after weeks of testimony.
Tile Setters and Asbestos: Flooring Risks
Tile setters faced asbestos exposure from vinyl asbestos tiles, adhesives, and backing materials. Learn about exposure sources and legal options.
Cold Lake School Closes After Asbestos Found
John D. Janvier School in Alberta closed in December 2025 after asbestos contamination found. Students relocated to temporary portables.
Steamfitters and Asbestos: High-Risk Trade
Steamfitters faced extreme asbestos exposure from steam pipe insulation, gaskets, and valve packing. Learn about exposure sources and legal options.
Malaysia Asbestos Ban Push Intensifies
Malaysia has not fully banned asbestos despite decades of advocacy. NGOs push for a ban as mesothelioma cases may double by 2045.
Sheet Metal Workers and Asbestos Risks
Sheet metal workers faced asbestos exposure from HVAC insulation, ductwork, and fireproofing materials. Learn about exposure sources and legal options.
Roofers and Asbestos Exposure Risks
Roofers faced asbestos exposure from shingles, felt, coatings, and adhesives. Learn about exposure sources, health risks, and legal options.
$25M Verdict Against J&J in Connecticut Mesothelioma Case
Connecticut judge adds $10M punitive damages to jury award in Evan Plotkin mesothelioma case against Johnson & Johnson over asbestos-contaminated talc.
U.S. Chamber Urges 5th Circuit to Vacate EPA Asbestos Ban
U.S. Chamber asks Fifth Circuit to vacate EPA's 2024 chrysotile asbestos ban. Court grants enforcement stay during review.
Measles Vaccine Gets FDA Orphan Drug for Meso
French biotech Oncovita receives FDA orphan drug designation for MVdeltaC, a modified measles virus showing 60-70% tumor reduction in mesothelioma models.
Refinery Workers and Asbestos Risks
Oil refinery workers faced extensive asbestos exposure from insulated equipment, pipes, and vessels. Learn about exposure sources and legal options.
Virginia Supreme Court: Shipyards Owe Duty to Families (Quisenberry, 2018)
Virginia's 2018 Quisenberry ruling held shipyard employers owe a duty of care to family members exposed to take-home asbestos.
J&J Talc Verdicts Top $2.5B in 2025
Johnson & Johnson faced over $2.5 billion in talc-related jury verdicts in 2025, including the largest individual award in litigation history.
Mesothelioma Treatment Advances: 2025
2025 saw major mesothelioma treatment advances including TEAD inhibitors, bispecific antibodies, and perioperative immunotherapy. Here's the full review.
Plasterers and Asbestos Exposure
Plasterers faced asbestos exposure from plaster additives, textured coatings, and fireproofing spray. Learn about exposure sources and legal options.
Pipefitters and Asbestos Exposure
Pipefitters faced significant asbestos exposure from insulated pipes, gaskets, and packing materials. Learn about exposure sources and legal options.
Painters and Asbestos: Prep Hazards
Painters faced asbestos exposure from surface preparation, sanding, and asbestos-containing paints and coatings. Learn about exposure sources.
Record $1.56B Verdict Against J&J in Talc
A Baltimore jury awarded $1.56 billion to Cherie Craft, a Maryland woman who developed mesothelioma after 40+ years of using Johnson & Johnson baby powder.
Operating Engineers and Asbestos Risks
Operating engineers faced asbestos exposure from heavy equipment brakes, building systems, and construction environments. Learn about exposure sources.
Millwrights and Asbestos: Machinery Risks
Millwrights faced asbestos exposure from industrial machinery insulation, gaskets, and packing materials. Learn about exposure sources and legal options.
$65.5M Verdict Against J&J in Minnesota Mesothelioma Case
A Minnesota jury awarded $65.5 million to a mother of three who developed mesothelioma after childhood exposure to Johnson & Johnson baby powder.
Merchant Marines and Asbestos Exposure
Merchant mariners faced extensive asbestos exposure from ship insulation, engine rooms, and living quarters. Learn about exposure sources and legal options.
Maintenance Workers and Asbestos Risks
Maintenance workers faced asbestos exposure from building insulation, mechanical systems, and repair work. Learn about exposure sources and legal options.
Longshoremen and Asbestos Exposure
Longshoremen faced asbestos exposure from ship cargo, dock facilities, and warehouse materials. Learn about exposure sources and legal options.
Libby Vermiculite Workers and Asbestos
Workers at Libby vermiculite exfoliation plants faced extreme asbestos exposure from contaminated ore. Learn about this unique exposure and legal options.
$40M Verdict Against J&J in California Ovarian Cancer Case
Los Angeles jury awards $40 million to two women who developed ovarian cancer after decades of using Johnson & Johnson talc-based body powders.
Construction Laborers and Asbestos Risks
Construction laborers faced asbestos exposure from demolition, cleanup, and working near other trades. Learn about exposure sources and legal options.
Ironworkers and Asbestos Exposure Risks
Ironworkers faced asbestos exposure from fireproofing spray, welding blankets, and structural insulation. Learn about exposure sources and legal options.
Insulators and Asbestos: Highest-Risk Trade
Insulators faced the highest asbestos exposure of any occupation, with mesothelioma rates 50-100x above normal. Health risks and options.
Hod Carriers and Asbestos Exposure Risks
Hod carriers faced asbestos exposure from handling and mixing construction materials. Learn about exposure sources and legal options.
Grinders and Asbestos Exposure: Work Risks
Grinders faced asbestos exposure from grinding wheels, brake work, and metal fabrication. Learn about exposure sources and legal options.
Glaziers and Asbestos: Window Risks
Glaziers faced asbestos exposure from window putty, caulking compounds, and fireproof glass assemblies. Learn about exposure sources.
Drug Combo Achieves 60% Response Rate
A Dutch trial found two drugs achieved a 60% response rate in mesothelioma patients whose cancer returned after immunotherapy.
Furnace Workers and Asbestos Risks
Furnace workers faced extreme asbestos exposure from refractory materials, insulation, and protective equipment. Learn about exposure sources.
FDA Withdraws Talc Asbestos Testing Rule
FDA withdrew its rule requiring asbestos testing in cosmetic talc. Public health advocates warn of ongoing contamination risks.
Floor Covering Workers: Asbestos Risk
Floor covering workers faced asbestos exposure from vinyl tiles, sheet goods, adhesives, and backing materials. Learn about exposure sources.
Drywallers and Asbestos: Joint Compound
Drywallers faced significant asbestos exposure from joint compound and texture materials. Learn about exposure sources and legal options.
Demolition Workers and Asbestos Risks
Demolition workers face extreme asbestos exposure when tearing down older buildings. Learn about exposure sources and legal options.
Carpenters and Asbestos Exposure
Carpenters faced asbestos exposure from drywall, ceiling tiles, flooring, and other building materials. Learn about exposure sources and legal options.
Building Inspectors and Asbestos Risks
Building inspectors faced asbestos exposure while inspecting older buildings with asbestos materials. Learn about exposure sources and legal options.
One Drug Halted, Another Advances
Novartis halted one experimental mesothelioma drug, but a competitor's TEAD inhibitor shows strong results in clinical trials.
Bricklayers and Asbestos Exposure
Bricklayers faced asbestos exposure from refractory materials, mortar additives, and fireproofing. Learn about exposure sources and legal options.
Cyncado to Test TT-4 in Australian Meso Trial
An Australian trial will test Cyncado's TT-4 A2B receptor antagonist in ~50 people with mesothelioma after first-line therapy.
Mesothelioma FAQ: Common Questions
Honest answers to common questions about mesothelioma diagnosis, prognosis, treatment options, legal rights, and caregiving. Based on real patient concerns.
Judge Allows Experts in 67,500 Talc Cases
Special master approves expert testimony in 67,500 J&J talc lawsuits, clearing the path for federal trials in ovarian cancer cases.
Tile Installers and Asbestos Exposure
Tile installers faced asbestos exposure from floor tiles, adhesives, and backing materials. Learn about vinyl asbestos tile risks and legal options.
Steel Workers and Asbestos Exposure
Steel mill workers faced extreme asbestos exposure from furnaces, ladles, and protective equipment. Learn about exposure sources and compensation options.
Shipyard Workers and Asbestos Exposure
Shipyard workers have the highest mesothelioma rates of any occupation. Learn about naval vessel asbestos use, exposure sources, and compensation options.
Japan Banned Asbestos in 2006, Cases Rise
Despite banning asbestos in 2006, Japan sees 1,500+ mesothelioma deaths yearly. The country's experience shows why bans alone aren't enough.
Abrasives Industry and Asbestos Exposure
Sand and abrasives manufacturing workers faced asbestos exposure from grinding wheels, sandpaper, and industrial abrasive products.
Offshore Workers and Asbestos Exposure
Offshore oil rig workers, platform crews, and support personnel faced asbestos exposure from insulation, equipment, and confined spaces.
Mining Industry and Asbestos Exposure
Miners faced asbestos exposure from direct mining operations, equipment insulation, and naturally occurring asbestos. Learn about exposure sources.
Maritime Workers and Asbestos Exposure
Maritime workers on commercial vessels faced extensive asbestos exposure in engine rooms, cargo holds, and living quarters. Learn about exposure sources.
Drywall Workers and Asbestos Exposure
Drywall workers face mesothelioma risk from asbestos in joint compound used until 1977. Studies found 59% of workers had lung changes from exposure.
Minot AFB Missile Crews Face Asbestos Risk
A 2025 federal study found missile alert facility workers at Minot AFB have increased cancer risk from asbestos in Cold War-era underground bunkers.
Mesothelioma Survival: 18-Year Survivor's Story
Diagnosed with peritoneal mesothelioma at 21 while pregnant, Tamron Little shares her 18-year journey and the reality of long-term survivorship.
Asbestos Manufacturing: Exposure Risks
Workers who manufactured asbestos products faced the highest exposure levels. Learn about insulation, roofing, and building material production risks.
Vermiculite Insulation & Asbestos Risks
Most US vermiculite insulation came from a contaminated mine. Learn how to identify Zonolite, understand the risks, and protect your family.
Asbestos in Popcorn Ceilings: Safety Guide
Popcorn ceilings installed before 1980 likely contain asbestos. Learn how to identify textured ceilings, understand exposure risks, and handle them safely.
$966M Verdict: J&J Concealed Talc Asbestos Risk
An LA jury awarded $966 million to the family of Mae Moore, an 88-year-old who died from mesothelioma after using Johnson & Johnson baby powder daily.
$966M Verdict Against J&J in California Mesothelioma Case
A Los Angeles jury awarded $966 million to the family of Mae Moore, 88, who died from mesothelioma after lifelong use of Johnson's Baby Powder.
Asbestos Pipe Insulation: Risks & Safety
Asbestos pipe insulation was widely used in homes and buildings through the 1970s. Learn to identify it, understand the risks, and handle it safely.
Asbestos Floor Tiles: Risks & Safety
Vinyl asbestos tiles were installed in millions of homes from the 1920s–1980s. Learn how to identify 9x9 tiles, understand the risks, and handle them safely.
Asbestos Ceiling Tiles: Risks & Safety
Acoustic ceiling tiles installed before 1980 often contain asbestos. Learn how to identify them, understand friability risks, and handle them safely.
The BAP1 Breakthrough: L-BAM Discovery
Dr. Michele Carbone's team identified L-BAM. A genetic form of mesothelioma with dramatically better outcomes than asbestos-related disease.
Steel Mill Workers and Asbestos Risks
Steel mill workers face elevated mesothelioma risk from asbestos used to protect against extreme heat. Studies show 2-4x higher disease rates.
Mesothelioma Awareness Day: September 26
September 26 is Mesothelioma Awareness Day. Learn about the history of awareness efforts, current statistics, and how to get involved.
Mesothelioma Treatment: Hopkins Immunotherapy Trial
Johns Hopkins phase 2 trial shows pre- and post-surgery immunotherapy is safe and effective for operable mesothelioma, with 28.6-month median survival.
Power Plant Workers: Asbestos Exposure Risk
Power plant workers face elevated mesothelioma rates from asbestos in boilers, turbines, and piping. Studies show 3-8x higher disease rates.
VT3989 Doubles Time Without Progression
Patients on VT3989 went 40 weeks without cancer progression. Vs. 15 weeks on standard chemo. FDA granted Fast Track status.
Hopkins: Pre-Surgery Immunotherapy Success
A Johns Hopkins trial found that immunotherapy before and after surgery extended median survival to 28.6 months, 10 months longer than average.
Trial Tests Immunotherapy Before Surgery
Baylor and Duke are testing immunotherapy before surgery for mesothelioma. Trial now enrolling operable patients.
IMPALA Trial: Light Therapy for Mesothelioma
The IMPALA trial in France is testing intrapleural photodynamic therapy combined with nivolumab for inoperable mesothelioma. Results expected mid-2026.
Textile Workers and Asbestos Exposure
Textile mill workers who manufactured asbestos cloth, rope, and fireproof fabrics face extremely high mesothelioma rates. Learn about exposure sources.
$3.3M Ford Asbestos Brake Verdict Upheld in NY
A New York appeals court upheld a $3.3M verdict against Ford after a former dealership worker was diagnosed with peritoneal mesothelioma from brake dust.
Paramount Studios Faces Asbestos Suits
Paramount Studios faces lawsuits alleging asbestos exposure on film sets and soundstages. The entertainment industry has a hidden asbestos history.
Oil Refinery Workers and Asbestos Risks
Oil refinery workers face elevated mesothelioma risk from asbestos insulation throughout refineries. Studies show 2-5x higher disease rates.
Railroad Workers and Asbestos Exposure Risks
Railroad workers face elevated mesothelioma risk from asbestos in locomotives, brake systems, and rail facilities. FELA provides unique legal options.
Asbestos in Cosmetics: Talc Risks
Talc-based cosmetics can contain asbestos contamination. Learn about the risks, recalled products, and how to protect yourself.
Paul Kraus: 27-Year Mesothelioma Survivor
Paul Kraus defied expectations for 27 years, becoming the world's longest-living mesothelioma survivor and patient advocate.
Teachers and School Staff: Asbestos Risk
Teachers and school staff face asbestos exposure from deteriorating building materials. EPA data shows 45,000+ schools contain asbestos.
$117M Asbestos Verdict Sets New York Record
A jury awarded $117M to a sheet metal worker exposed to asbestos at the original World Trade Center, the largest such verdict in New York history.
Asbestos Disclosure Bill H.R.4247
H.R.4247 would require sellers and landlords to disclose known asbestos hazards before completing sales or leases of residential properties.
Boilermakers: High Mesothelioma Risk Trade
Boilermakers face mesothelioma rates 5-10x higher than average. Research shows decades of asbestos exposure in power plants and industrial settings.
HVAC Technicians and Asbestos Risks
HVAC workers face mesothelioma risk from asbestos in duct insulation, boilers, and old equipment. Learn about exposure sources and protection.
Libby, Montana: America's Deadliest Town
The Libby, Montana, asbestos disaster killed 400+ residents. Decades later, EPA cleanup continues and health monitoring tracks thousands affected.
Dual-Target Immunotherapy Shows 52% Response
BioNTech's dual-target immunotherapy achieved a 52% response rate in people with mesothelioma. Results presented at ASCO 2025.
Genetic Factors in Mesothelioma Risk
While asbestos causes most mesothelioma, genetic factors like BAP1 mutations and Lynch syndrome can increase risk. Learn what genetics reveal.
UK Commits £1.2B for Asbestos Removal
UK government allocates £470 million for 656 schools and £750 million for NHS sites to address asbestos, crumbling infrastructure in 2025-2026.
Auto Mechanics and Asbestos: Brake Dust Risk
Auto mechanics face mesothelioma risk from asbestos in brake pads and clutches. Learn about exposure history, current risks, and protection.
Electricians and Asbestos: Mesothelioma Risk
Electricians face mesothelioma risk from asbestos in electrical panels, wire insulation, and work near other trades. Learn about exposure sources.
Plumbers & Pipefitters: Asbestos Risk
Plumbers and pipefitters face elevated mesothelioma risk from decades of asbestos exposure in pipe insulation, gaskets, and joint compounds.
Asbestos in Schools: Parent Guide
An estimated 107,000 U.S. schools contain asbestos. Learn about AHERA regulations, risks to students and staff, and what schools must do.
Asbestos in Homes: Renovation Safety
Millions of homes contain asbestos. Learn where it's found, when it's dangerous, and how to protect your family during renovation or repair.
Mesothelioma Diet & Nutrition Guide
Proper nutrition supports mesothelioma treatment outcomes. Learn about caloric needs, protein requirements, and managing treatment side effects.
Getting a Second Opinion for Mesothelioma
Mesothelioma is rare and often misdiagnosed. Learn why getting a second opinion is crucial and how to find specialized mesothelioma experts.
Dr. Harvey Pass: Biomarker Pioneer
Dr. Harvey Pass has led the search for mesothelioma biomarkers. Blood tests that could detect the disease when treatment is most effective.
Mesothelioma Staging: TNM System Guide
Mesothelioma staging determines treatment options and prognosis. Learn about the TNM system, survival rates by stage, and what staging means for you.
UK Has World's Highest Meso Rates
Britain records 2,700+ mesothelioma deaths annually, the highest rate globally. Here's what the UK experience teaches us about asbestos disease.
Choosing a Mesothelioma Treatment Center
Mesothelioma requires specialized care. Learn what makes a treatment center qualified and how to find the right team for your diagnosis.
Canada Banned Asbestos, Cases Still Rise
Despite banning asbestos, Canada sees 472 mesothelioma deaths annually. Legacy asbestos in buildings and the disease's long latency explain the trend.
Mesothelioma Caregiver Guide for Families
Caregiving for a mesothelioma patient is demanding. Learn practical tips for managing symptoms, appointments, emotions, and your own well-being.
Military Veterans and Asbestos Exposure
Veterans account for nearly one-third of mesothelioma cases. Learn about asbestos exposure across all military branches and available benefits.
Mesothelioma Latency Period: 20-50 Years
Mesothelioma has a 20-50 year latency period between asbestos exposure and diagnosis. Learn why the gap exists and what it means for patients.
FDA Approves Opdivo Qvantig for Mesothelioma
FDA approval of Opdivo Qvantig allows subcutaneous nivolumab delivery in under 5 minutes, compared to 30-minute IV infusions for people with mesothelioma.
Utah Windstorm Spreads Mine Asbestos
A 2024 windstorm scattered asbestos-contaminated vermiculite mine tailings near Park City, Utah, prompting EPA monitoring and community health concerns.
How to File a Talcum Powder Lawsuit
Everything you need to file a talc cancer claim: eligibility, documents needed, timeline, and what to expect from the legal process.
Wittenoom: Australia's Blue Asbestos Ghost Town
Australia's Wittenoom mining town became the nation's deadliest industrial disaster. More than 2,000 people have died from asbestos exposure.
Is Talcum Powder Safe? 2026 Update
The WHO says talc is 'probably carcinogenic.' J&J discontinued talc baby powder. Here's what the science says and what you should do.
Paul Gleason: Breakfast Club Actor's Mesothelioma
Actor Paul Gleason, best known as Principal Vernon in The Breakfast Club, died of pleural mesothelioma in 2006, three weeks after diagnosis.
KEYNOTE-483: Keytruda Combo Approved
KEYNOTE-483 Phase 3 trial shows pembrolizumab plus chemotherapy improves survival to 17.3 months. FDA approved September 2024 for first-line treatment.
Talcum Powder Settlements & Verdicts
Talc verdicts range from $55 million to $1.56 billion, but appeals have vacated or reversed many. See what is standing, reduced, or gone.
FDA Approves Keytruda Combo for Mesothelioma
The FDA approved pembrolizumab (Keytruda) with chemotherapy for advanced pleural mesothelioma, showing a 21% reduction in death risk in the KEYNOTE-483 trial.
Multimodal Mesothelioma Treatment Guide
Multimodal therapy doubles mesothelioma survival rates. Trimodal protocols, HIPEC for peritoneal, and patient selection criteria explained.
9/11 Mesothelioma Crisis Still Unfolding
The mesothelioma toll among 9/11 first responders and survivors is just beginning. Experts warn the worst is yet to come.
Leonard Bernstein: The Maestro's Final Years
Leonard Bernstein, creator of West Side Story and conductor of the New York Philharmonic, battled lung disease including a pleural tumor in his final years.
Firefighters and Asbestos: Cancer and Laws
Firefighters have 2x higher mesothelioma risk. IARC classifies firefighting as Group 1 carcinogen. 9/11 data, presumptive laws by state explained.
Libby, Montana: The Asbestos Tragedy
Libby's vermiculite mine killed hundreds and sickened thousands with asbestos-contaminated dust. The disaster continues today.
Dr. David Sugarbaker: Mesothelioma Pioneer
Dr. David Sugarbaker's contributions to mesothelioma surgery and training continue to shape how the disease is treated worldwide.
Shipyard Workers and Mesothelioma Risk
Shipyard workers face significantly elevated mesothelioma rates. WWII-era exposure, Navy shipyards, and ongoing risks from ship repair work explained.
Stephen Jay Gould: The Median Isn't the Message
When Stephen Jay Gould was diagnosed with mesothelioma and given 8 months to live, he wrote an essay that still gives hope to patients.
Construction Workers and Asbestos Risks
Construction workers face elevated mesothelioma risk. Insulators, carpenters, and demolition crews have highest exposure from legacy asbestos materials.
Products That Contain Talc: A Complete Guide
Baby powder, cosmetics, and more. Learn which products contain talc, which have been recalled, and what safer alternatives exist.
DENIM Trial: Vaccine Did Not Extend Survival
The Phase 2/3 DENIM trial found that dendritic cell vaccination did not extend overall survival for people with mesothelioma after chemotherapy.
Merlin Olsen: NFL Legend's Mesothelioma
Hall of Fame defensive tackle Merlin Olsen, 14-time Pro Bowler and actor, died of mesothelioma in 2010 after asbestos exposure from childhood construction work.
WHO Classifies Talc as Probable Carcinogen
IARC upgrades talc to Group 2A carcinogen in July 2024 based on ovarian cancer links and asbestos contamination concerns.
VA Benefits for Mesothelioma Veterans
Once service-connected, mesothelioma is generally rated at 100% VA disability ($48,000+/year tax-free). Includes Priority Group 1 healthcare and survivor DIC.
Talcum Powder and Ovarian Cancer: The Complete Guide
Over 90,000 lawsuits allege talc caused ovarian cancer. IARC classifies talc as probably carcinogenic. Verdicts exceed $2.5 billion.
Steve McQueen and Asbestos Exposure
How Steve McQueen developed mesothelioma from asbestos exposure during Marine Corps service, and what his story reveals about veterans' risk.
Mesothelioma Legal Options and Compensation
Understand your legal options after a mesothelioma diagnosis. Lawsuits, asbestos trust funds, VA benefits, and workers' compensation explained.
The Johns-Manville Cover-Up: A Hidden Epidemic
Documents reveal how Johns-Manville executives knew asbestos was killing workers decades before disclosure, including the infamous 1935 letters.
MARS 2: Chemo Outperformed Surgery
The landmark MARS 2 trial found that chemotherapy alone led to better survival than surgery plus chemotherapy for people with pleural mesothelioma.
Talcum Powder Lawsuits: Complete Guide
About 90,000 talcum powder lawsuits allege cancer from J&J products. Learn about eligibility, verdicts, settlements, and how to file a claim.
EPA Bans Chrysotile: First U.S. Asbestos Ban
EPA bans chrysotile asbestos in March 2024 under TSCA. Phase-out periods of 5–12 years for remaining industrial uses.
Dr. Irving Selikoff: Exposing Asbestos Danger
Dr. Irving Selikoff's 1964 research documenting the link between asbestos and cancer remains foundational to mesothelioma science.
Talcum Powder and Cancer: Consumer Guide
Over 90,000 lawsuits allege talc caused cancer. The asbestos connection, affected products, and options for people exposed to talc.
ATOMIC-Meso: Quadrupled 3-Year Survival
The ATOMIC-Meso trial showed pegargiminase plus chemotherapy quadrupled 3-year survival rates in nonepithelioid mesothelioma, the most aggressive subtype.
CONFIRM Trial: Nivolumab Extends Survival in Relapsed Mesothelioma
CONFIRM (Phase 3, 332 patients) showed nivolumab improved median OS to 10.2 vs 6.9 months in relapsed mesothelioma. PD-L1 did not predict benefit.
2023 Mesothelioma Verdicts: $40M+ Awards
Major mesothelioma verdicts in 2023 included $40.5M in Illinois and $38M in New York as juries continue holding asbestos defendants accountable.
Warren Zevon: 'Enjoy Every Sandwich'
Warren Zevon's final months remain a powerful example of facing mortality with honesty and creativity after his mesothelioma diagnosis.
Court Rejects J&J's 2nd Talc Bankruptcy
A federal judge rejected Johnson & Johnson's $8.9 billion settlement plan in July 2023, ruling the LTL Management bankruptcy was filed in bad faith.
SynKIR-110 CAR-T Gets FDA Fast-Track
FDA grants fast-track to SynKIR-110 CAR-T therapy for mesothelioma. Phase 1 trial recruiting at MD Anderson, Penn, and more.
J&J Discontinues Talc Baby Powder
J&J ends talc-based baby powder sales worldwide in 2023, switching to cornstarch. Decision follows 60,000+ lawsuits over asbestos contamination.
EPA Proposes Chrysotile Asbestos Ban
In April 2022, the EPA proposed banning chrysotile asbestos, the only form still imported into the U.S., primarily used by the chlor-alkali industry.
J&J Creates LTL to Shield Talc Liability
Johnson & Johnson used a Texas Two-Step maneuver to transfer talc liabilities to LTL Management, which filed for bankruptcy in October 2021.
J&J's Texas Two-Step: 3 Failed Attempts
Johnson & Johnson's controversial bankruptcy strategy to avoid 90,000+ talc cancer lawsuits failed three times between 2021 and 2024.
CAR-T Cell Therapy for Mesothelioma
CAR-T cells target mesothelin on mesothelioma cells. SynKIR-110 received FDA fast-track designation in April 2023. Multiple trials recruiting.
FDA OKs Opdivo+Yervoy for Mesothelioma
In October 2020, the FDA approved nivolumab plus ipilimumab as the first immunotherapy for mesothelioma, marking the first new treatment in 16 years.
Mesothelioma Immunotherapy: FDA Options
Nivolumab plus ipilimumab improves survival to 18 months. See FDA-approved immunotherapies and current clinical trials.
CheckMate-743: Immunotherapy Beats Chemo
CheckMate-743 trial shows nivolumab plus ipilimumab extends median survival to 18.1 months vs 14.1 months with chemotherapy. 3-year survival doubles.
$750M Verdict Against J&J in New Jersey Mesothelioma Cases
In June 2020, a New Jersey jury awarded $750 million to four mesothelioma patients who blamed Johnson & Johnson talc products for their cancers.
Checkpoint Inhibitors for Mesothelioma
Checkpoint inhibitors like nivolumab and pembrolizumab release the brakes on the immune system. Learn how PD-1 and CTLA-4 blockers treat mesothelioma.
Talc and Mesothelioma: Asbestos Risks
Peer-reviewed study: 122 mesothelioma cases had talc as ONLY asbestos source. 73.5% of talc-exposed patients had no other exposure.
Chris Placitella on 40 Years of Asbestos Trials
Asbestos trial attorney Chris Placitella discusses 40 years of litigation, what corporations knew, and the talc connection in this MesoWatch interview.
Mesothelioma Statistics & Survival Rates
Comprehensive mesothelioma statistics including annual diagnoses, survival rates by stage, and demographic data from CDC, SEER, and NIH sources.
FDA Finds Asbestos in J&J Baby Powder
In October 2019, FDA testing found asbestos in J&J Baby Powder for the first time, triggering a voluntary recall of 33,000 bottles.
Mesothelioma Second-Line Treatment Options
When first-line chemo fails, second-line options include gemcitabine, immunotherapy combinations, and clinical trials. PEMMELA trial showed 58% response.
Mesothelioma Clinical Trials Guide
Guide to finding mesothelioma clinical trials on ClinicalTrials.gov. Active studies include CAR-T therapy, immunotherapy combinations, and targeted drugs.
FDA Approves Optune Lua for Mesothelioma
In May 2019, the FDA approved the NovoTTF-100L System (Optune Lua) for mesothelioma, the first new treatment option since pemetrexed in 2004.
TTFields for Mesothelioma: Optune Lua
Tumor Treating Fields (Optune Lua) is FDA-approved for mesothelioma. Uses electric fields to disrupt cancer cell division with minimal side effects.
FDA Finds Asbestos in Claire's Makeup
FDA testing in 2019 detected asbestos in children's cosmetics from Claire's, Justice, and other brands. Products marketed to teens and children.
Mesothelioma in Women: Survival Rates
Women with mesothelioma have 3x better 5-year survival than men. 91% of female cases are from secondary household asbestos exposure.
Veterans Are Disproportionately Affected by Mesothelioma
Veterans account for a significant share of U.S. mesothelioma cases. Learn about Navy exposure, VA benefits, and why service members face elevated risk.
$4.69B Verdict Against J&J in St. Louis Talc Case
July 2018 verdict awarded 22 women $4.69 billion for ovarian cancer linked to J&J baby powder, the largest talc verdict in history at the time.
Mesothelioma Chemotherapy: Drugs and Response
Pemetrexed plus cisplatin extends median survival to 12.1 months. Response rates vary by cell type: epithelioid 16.5 months vs sarcomatoid 8.8 months.
Mesothelioma Misdiagnosis: 22.6% Missed
Up to a quarter of mesothelioma cases are first misdiagnosed. Learn the conditions it's confused with and why a second opinion matters.
Air Force Veterans & Mesothelioma: Risks
Air Force veterans were exposed to asbestos in aircraft, hangars, and base buildings. Learn about exposure risks and VA disability benefits.
Army Veterans & Mesothelioma: Base Exposure
Army veterans face elevated mesothelioma risk from asbestos in barracks, vehicles, and equipment. Learn about exposure sources and VA benefits.
Coast Guard Veterans: Shipboard Asbestos
Coast Guard veterans share the Navy's high mesothelioma risk from shipboard asbestos. Learn about exposure on cutters and compensation options.
Marine Veterans & Mesothelioma: Exposure
Marine veterans faced asbestos exposure aboard Navy ships and at bases like Camp Lejeune and Camp Pendleton. Learn about risks and VA benefits.
Navy Veterans & Mesothelioma: Shipyard Risks
Navy veterans face elevated mesothelioma rates from shipboard asbestos. Learn about exposure risks, VA benefits, and specialized treatment centers for veterans.
HIPEC for Peritoneal Mesothelioma: Survival
CRS/HIPEC achieves 53-103 month median survival for peritoneal mesothelioma. 28-year data shows survival curves flatten after year 6, signaling long-term cure.
Asbestos Trust Funds for Mesothelioma
Over $30 billion remains in roughly 60 active asbestos trust funds. Learn about payouts, filing claims, and how compensation stacks.
Pericardial Mesothelioma: Rare Heart Cancer
Pericardial mesothelioma affects the heart lining and accounts for less than 1% of cases. Learn about symptoms, diagnosis challenges, and treatment options.
Testicular Mesothelioma: Rarest Form
Testicular mesothelioma affects less than 1% of patients but has the best prognosis. 49% five-year survival, symptoms, treatment, and outlook.
Brazil Bans Asbestos in Landmark 2017 Ruling
Brazil's Supreme Court banned asbestos in November 2017, ruling 7-2 that federal 'safe use' laws violated constitutional health rights.
Mesothelioma Blood Tests & Biomarkers
MESOMARK blood test detects elevated SMRP levels in mesothelioma. Learn about biomarkers for monitoring and early detection research.
Mesothelioma Radiation Therapy: IMRT Guide
Radiation therapy can control tumor growth and relieve symptoms for people with mesothelioma. Learn about IMRT, when radiation is used, and what to expect.
Secondary Asbestos Exposure: Family Risks
Family members of asbestos workers can develop mesothelioma from take-home exposure. Learn how secondary exposure occurs and what to do if you were exposed.
Mesothelioma Palliative Care Guide
Palliative care improves quality of life for people with mesothelioma. Learn about symptom management, hospice eligibility, and support options.
Mesothelioma Cell Types Explained
Cell type determines mesothelioma prognosis. Epithelioid has best outcomes (~70% of cases). Learn how histology affects treatment response.
Mesothelioma Surgery: P/D vs EPP Options
Surgery can extend survival for eligible people with mesothelioma. Compare pleurectomy/decortication and extrapleural pneumonectomy options.
Mesothelioma Diagnosis and Staging Explained
Most mesothelioma cases are found at later stages. Learn how staging works, survival rates by stage, and why earlier detection improves outcomes.
Asbestos Exposure Sites by State
Documented asbestos exposure sites by state: industrial hubs, shipyards, and mills where workers faced asbestos risk. Search facilities in your state.
High-Risk Occupations for Asbestos Exposure
Millions of U.S. workers were exposed to asbestos 1940-1979. Insulators and shipyard workers face the highest mesothelioma rates.
Lautenberg Act: Path to Asbestos Ban
The 2016 Lautenberg Act reformed TSCA for the first time in 40 years, designating asbestos as one of the first 10 chemicals for EPA risk evaluation.
Asbestos Exposure: Risks & What to Do
Asbestos exposure causes mesothelioma 20-50 years later. Learn how exposure happens, high-risk occupations, and steps to take if you were exposed.
Mesothelioma Life Expectancy: Data & Stats
Mesothelioma life expectancy averages 12-21 months. Early-stage patients with multimodal treatment can reach 32+ months.
Mesothelioma Prognosis & Life Expectancy
Mesothelioma prognosis depends on stage, cell type, and treatment. Learn what factors influence survival and how to improve your outlook.
Mesothelioma Treatment Options Overview
Complete guide to mesothelioma treatment options. Multimodal treatment achieves 32-month median survival. Learn about surgery, chemo, and immunotherapy.
Mesothelioma Symptoms: Early Warning Signs
Mesothelioma symptoms often mimic common conditions. Learn the warning signs of pleural, peritoneal, and other types. Early detection improves survival.
Peritoneal Mesothelioma: 50% Survival Rates
Peritoneal mesothelioma affects the abdominal lining. With HIPEC surgery, 5-year survival reaches 47-52%. Learn symptoms, treatment, and prognosis.
Pleural Mesothelioma: Symptoms & Treatment
Pleural mesothelioma accounts for 81% of US cases (CDC 2003-2022). Learn about symptoms, staging, treatment options, and SEER 5-year survival of 12%.
Mesothelioma Causes & Risk Factors
Asbestos exposure is the only proven cause of mesothelioma. Learn how asbestos fibers cause cancer, who is at risk, and the 20-50 year latency period.
What is Mesothelioma?
Mesothelioma is a rare cancer caused by asbestos. Learn about types, symptoms, causes, and survival rates from independent medical sources.
Zadroga Act: Permanent Care for 9/11 Responders
The 2015 Zadroga Act reauthorization made the World Trade Center Health Program permanent, ensuring continued care for 9/11 responders.
BAP1 Gene Mutation and Mesothelioma
BAP1 germline mutations raise mesothelioma risk after low asbestos exposure. Testa 2011 (PMID 21874000) anchors the syndrome.